Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.07.009
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Elsevier BV